{"id":4200,"date":"2020-04-22T14:58:12","date_gmt":"2020-04-22T12:58:12","guid":{"rendered":"https:\/\/www.seedcapitalbizkaia.eus\/?p=4200"},"modified":"2021-03-01T11:14:10","modified_gmt":"2021-03-01T09:14:10","slug":"histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19","status":"publish","type":"post","link":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/","title":{"rendered":"Histocell participates in a clinical trial of cell therapy against Covid-19"},"content":{"rendered":"<p><a href=\"https:\/\/www.histocell.com\/en\/\">Histocell<\/a>, a company from Biscay in which <a href=\"https:\/\/www.seedcapitalbizkaia.eus\/en\/\">Seed Capital Bizkaia<\/a> participates, will shortly start the clinical trial of its cell therapy drug at Cruces Hospital with a group of 26 patients with respiratory problems caused by COVID-19.<\/p>\n<p>People affected with respiratory distress (ARDS) derived from Covid-19 infection meet the criteria to participate in this Clinical Trial that aims to help the patient overcome the ARDS situation, as well as decrease the mortality rate and the damages caused in the medium\/long-term in lung tissue.<strong>\u00a0<\/strong><\/p>\n<h3><strong>ARDS, the most serious complication<\/strong><\/h3>\n<p>More than 40% of severely hospitalized people develop ARDS, and about 50% with moderate-severe ARDS dies due to this syndrome. Therefore, these data show that Acute Respiratory Distress Syndrome (ARDS) represents the most serious complication of Covid-19 infection.<\/p>\n<h3><strong>HC016, the result of a long development work<\/strong><\/h3>\n<p>Histocell has been developing for years a cell therapy drug for ARDS, called HC016, based on adult stem cells obtained from adipose tissue designed to survive in highly inflammatory environments. Thus, HC016 cells are especially suitable for the treatment of ARDS that appears in people with Covid-19.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Histocell, a company from Biscay in which Seed Capital Bizkaia participates, will shortly start the clinical trial of its cell therapy drug at Cruces Hospital&#8230;<\/p>\n","protected":false},"author":2,"featured_media":2460,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-4200","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-eu-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Histocell participates in a clinical trial of cell therapy against Covid-19 - Seed Capital Bizkaia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Histocell participates in a clinical trial of cell therapy against Covid-19 - Seed Capital Bizkaia\" \/>\n<meta property=\"og:description\" content=\"Histocell, a company from Biscay in which Seed Capital Bizkaia participates, will shortly start the clinical trial of its cell therapy drug at Cruces Hospital...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Seed Capital Bizkaia\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-22T12:58:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-01T09:14:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1812\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"seed.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"seed.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/\"},\"author\":{\"name\":\"seed.com\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/9f7fe51a3f998da35b8377c79e654262\"},\"headline\":\"Histocell participates in a clinical trial of cell therapy against Covid-19\",\"datePublished\":\"2020-04-22T12:58:12+00:00\",\"dateModified\":\"2021-03-01T09:14:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/\"},\"wordCount\":190,\"image\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/\",\"name\":\"Histocell participates in a clinical trial of cell therapy against Covid-19 - Seed Capital Bizkaia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"datePublished\":\"2020-04-22T12:58:12+00:00\",\"dateModified\":\"2021-03-01T09:14:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/9f7fe51a3f998da35b8377c79e654262\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"width\":2560,\"height\":1812,\"caption\":\"Histocell Seed Capital Bizkaia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Histocell participates in a clinical trial of cell therapy against Covid-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#website\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/\",\"name\":\"Seed Capital Bizkaia\",\"description\":\"Seed Capital Bizkaia\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/9f7fe51a3f998da35b8377c79e654262\",\"name\":\"seed.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g\",\"caption\":\"seed.com\"},\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/en\\\/author\\\/seed-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Histocell participates in a clinical trial of cell therapy against Covid-19 - Seed Capital Bizkaia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/","og_locale":"en_US","og_type":"article","og_title":"Histocell participates in a clinical trial of cell therapy against Covid-19 - Seed Capital Bizkaia","og_description":"Histocell, a company from Biscay in which Seed Capital Bizkaia participates, will shortly start the clinical trial of its cell therapy drug at Cruces Hospital...","og_url":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/","og_site_name":"Seed Capital Bizkaia","article_published_time":"2020-04-22T12:58:12+00:00","article_modified_time":"2021-03-01T09:14:10+00:00","og_image":[{"width":2560,"height":1812,"url":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","type":"image\/jpeg"}],"author":"seed.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"seed.com","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/#article","isPartOf":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/"},"author":{"name":"seed.com","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/9f7fe51a3f998da35b8377c79e654262"},"headline":"Histocell participates in a clinical trial of cell therapy against Covid-19","datePublished":"2020-04-22T12:58:12+00:00","dateModified":"2021-03-01T09:14:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/"},"wordCount":190,"image":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","articleSection":["Noticias"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/","url":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/","name":"Histocell participates in a clinical trial of cell therapy against Covid-19 - Seed Capital Bizkaia","isPartOf":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","datePublished":"2020-04-22T12:58:12+00:00","dateModified":"2021-03-01T09:14:10+00:00","author":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/9f7fe51a3f998da35b8377c79e654262"},"breadcrumb":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/#primaryimage","url":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","contentUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","width":2560,"height":1812,"caption":"Histocell Seed Capital Bizkaia"},{"@type":"BreadcrumbList","@id":"https:\/\/www.seedcapitalbizkaia.eus\/en\/histocell-participates-in-a-clinical-trial-of-cell-therapy-against-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.seedcapitalbizkaia.eus\/en\/"},{"@type":"ListItem","position":2,"name":"Histocell participates in a clinical trial of cell therapy against Covid-19"}]},{"@type":"WebSite","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#website","url":"https:\/\/www.seedcapitalbizkaia.eus\/","name":"Seed Capital Bizkaia","description":"Seed Capital Bizkaia","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seedcapitalbizkaia.eus\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/9f7fe51a3f998da35b8377c79e654262","name":"seed.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g","caption":"seed.com"},"url":"https:\/\/www.seedcapitalbizkaia.eus\/en\/author\/seed-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/posts\/4200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/comments?post=4200"}],"version-history":[{"count":3,"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/posts\/4200\/revisions"}],"predecessor-version":[{"id":5047,"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/posts\/4200\/revisions\/5047"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/media\/2460"}],"wp:attachment":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/media?parent=4200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/categories?post=4200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/en\/wp-json\/wp\/v2\/tags?post=4200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}